Overview

Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas (Study P04460)

Status:
Withdrawn
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
This open-label, randomized, parallel-group clinical study is designed to compare the efficacy and safety of the topical antibiotic, sisomicin cream, with that of another topical antibiotic cream, nadifloxacin cream, in the treatment of Indian patients with primary pyodermas.
Phase:
Phase 4
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Collaborator:
Fulford India Limited
Treatments:
Nadifloxacin
Sisomicin